DayTwo Funding & Investors
Walnut Creek, CA
DayTwo is a precision nutrition company that uses food as medicine to enable a path to remission for metabolic diseases including diabetes, prediabetes, clinical obesity, NAFLD. DayTwo's groundbreaking scientific discovery, published in CELL (2015) and JAMA (2019) determined that people respond differently to the same food, thus knowing what food “works” for each person is crucial to an effective care plan. DayTwo uses gut microbiome sequencing (stool sample, akin to Cologuard) to create Food Prescriptions™ for each patient which balance blood sugar levels, improve energy, manage hunger, and help members lose weight. The DayTwo virtual care solution is delivered through Certified Diabetes Care and Education Specialists and Registered Dietitians using a digital app to track progress and to communicate with members. DayTwo uses A1C and Time In Range as the primary clinical outcomes, and weight as a secondary outcome. For those who implement the DayTwo protocol, DayTwo offers up to 100% fees-at-risk.
daytwo.comTotal Amount Raised:
DayTwo Funding Rounds
Series B
37,414,821 GBP
Series B Investors
Jacky AbitbolYair SchindelPoalim EquityVolta CircleCathay InnovationMicron TechnologyaMoon Fund10DLa Maison PartnersSeries B
$5,000,000
Series B Investors
Longliv VenturesCathay InnovationSamsung NextSeries B
$31,000,000
Series B Investors
10DaMoon FundOmri CasspiJohnson & JohnsonSeventure PartnersSamsung NextLongliv VenturesCathay InnovationSeries A
$12,000,000
Series A Investors
Johnson & JohnsonMarius NachtMayo ClinicFrench Investment FundSeventure PartnersCentury PartnersSeed
$5,000,000